Editorial
Published on 08 Dec 2023
Editorial: Drug discovery for emerging and neglected tropical diseases: advances, challenges and perspectives
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1346042
- 2,074 views
- 1 citation
156 Publications
volumes
Volume 3 - 2023
Review
Published on 01 Dec 2023
Latest development of approved COVID-19 drugs and COVID-19 drugs undergoing late stage clinical trials
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1304129
- 5,163 views
- 7 citations
Mini Review
Published on 30 Nov 2023
Introduction to small molecule drug discovery and preclinical development
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1314077
- 75,934 views
- 57 citations
Mini Review
Published on 27 Nov 2023
HyBryte™ use in early-stage cutaneous T-cell lymphoma
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1298453
- 3,689 views
Editorial
Published on 23 Nov 2023
Editorial: Advances in anti-malarial drug discovery
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1335842
- 2,257 views
- 2 citations
Original Research
Published on 22 Nov 2023
Targeting a cancer-specific LYPD3 glycoform for tumor therapy
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1298916
- 4,739 views
- 3 citations
Review
Published on 21 Nov 2023
Future treatments for the arteriopathy of ectopic calcification disorders
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1249966
- 3,837 views
Original Research
Published on 14 Nov 2023
In vitro drug interaction of ionophores with artemisinin and chloroquine against Plasmodium falciparum 3D7 blood-stage infection
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1257698
- 2,739 views
- 1 citation
Original Research
Published on 30 Oct 2023
An improved method for large scale generation and high-throughput functional characterization of human iPSC-derived microglia
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1289314
- 4,419 views
Review
Published on 18 Sep 2023
State-of-the-art strategies to prioritize Mycobacterium tuberculosis drug targets for drug discovery using a subtractive genomics approach
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1254656
- 4,263 views
- 7 citations
Mini Review
Published on 05 Sep 2023
Harnessing bioluminescence for drug discovery and epigenetic research
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1249507
- 5,478 views
- 6 citations
Brief Research Report
Published on 03 Aug 2023
Novel mesothelin antibodies enable crystallography of the intact mesothelin ectodomain and engineering of potent, T cell-engaging bispecific therapeutics
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1216516
- 6,805 views
- 6 citations
Review
Published on 25 Jul 2023
The importance of good practices and false hits for QSAR-driven virtual screening real application: a SARS-CoV-2 main protease (Mpro) case study
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1237655
- 5,082 views
- 9 citations
Original Research
Published on 20 Jul 2023
9-PAHSA displays a weak anti-inflammatory potential mediated by specific antagonism of chemokine G protein-coupled receptors
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1138461
- 4,445 views
- 1 citation
Review
Published on 13 Jul 2023
Targeting proteases and proteolytic processing of unusual N-terminal extensions of Plasmodium proteins: parasite peculiarity
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1223140
- 2,925 views
- 3 citations
Mini Review
Published on 12 Jul 2023
FAIR data management: what does it mean for drug discovery?
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1226727
- 4,131 views
- 11 citations
Original Research
Published on 07 Jul 2023
The tumor suppressor 5A2, a synthetic miR-7-5p mimic, targets oncogenic and metabolic pathways, as revealed by transcriptome-wide analysis
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1181637
- 2,604 views
- 1 citation
Review
Published on 21 Jun 2023
Yin-yang in drug discovery: rethinking de novo design and development of predictive models
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1222655
- 7,339 views
- 6 citations
Original Research
Published on 15 Jun 2023
MMV006087 is a potent Malaria Box compound against Plasmodium falciparum clinical parasites
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1190471
- 3,483 views
- 2 citations
Review
Published on 01 Jun 2023
Lessons that can be learned from the SARS-CoV-2 pandemic and their impact on the prophylaxis and treatment development for neglected tropical arboviruses
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1176768
- 5,690 views
Mini Review
Published on 24 May 2023
Drug discovery and development: introduction to the general public and patient groups
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1201419
- 214,053 views
- 188 citations
Review
Published on 10 May 2023
The critical role of mode of action studies in kinetoplastid drug discovery
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1185679
- 4,559 views
- 11 citations
Original Research
Published on 09 May 2023
Generation of a potent anti-PD-L1-CD47 bispecific antibody with a strong therapeutic and safety profile for cancer immunotherapy
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1182146
- 6,161 views
- 1 citation
Editorial
Published on 27 Feb 2023
Editorial: Development/repurposing of drugs to tackle the multiple variants of SARS-CoV-2
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1157688
- 1,711 views
- 2 citations